Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery

Completed · Phase 2 · Has a placebo group

Conditions studied: Scar Formation

In brief

The primary objective of this study is to assess whether intradermal injections of GBT009 along full thickness incisions following surgery results in an improvement in scar appearance.

Key facts

Study ID

NCT01053897

Run by

Garnet BioTherapeutics, Inc.

People needed

5

Starts

2010-01-01

Expected to finish

2011-10-01

Last updated by the study team

2013-10-24

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Garnet BioTherapeutics Investigational Site — Chicago, Illinois, United States
• Garnet BioTherapeutics Investigational Site — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.